F. Mefti - Concepedia

Author

F. Mefti

Hôpital René Huguenin

Also Known As

F Mefti, F. Mefti, Fawzia Mefti

Publications

510

Citations

H-Index

Concepts

All Affiliations

Hôpital René Huguenin Institut Curie Institut de Cancérologie de l'Ouest Sorbonne Université Inserm

About

F. Mefti is an author at Hôpital René Huguenin specializing in medicine, breast cancer, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	190
2	Health Sciences	2	2	50
3	Cell Biology	1	1	20
4	Obstetrics	1	1	45
5	Pathology	1	1	20

F. Mefti

Publications

489

Citations

H-Index

Page 1

	Year	Citations
First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity Chrystelle Brignone, Maya Gutierrez, F. Mefti, Journal of Translational Medicine	2010	253
Phase I feasibility study for intrathecal administration of trastuzumab in patients with HER2 positive breast carcinomatous meningitis Claire Bonneau, Gilles Paintaud, Olivier Trédan, European Journal of Cancer Breast OncologyIntrathecal AdministrationBreast CancerBreast SurgeryScleroderma	2018	95
Health-related quality of life in recurrent platinum-sensitive ovarian cancer—results from the CALYPSO trial Michael Brundage, M. Gropp, F. Mefti, Annals of Oncology Health-related QualityMedicineCancer ManagementGynecologyCancer Treatment	2012	45
Impact of geriatric risk factors on pegylated liposomal doxorubicin tolerance and efficacy in elderly metastatic breast cancer patients: Final results of the DOGMES multicentre GINECO trial Claire Falandry, Étienne Brain, Marc Bonnefoy, European Journal of Cancer Final ResultsBreast OncologyOncologyLiposomal Doxorubicin ToleranceMedicine	2013	30
First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study Djelila Allouache, Sulochana R. Gawande, M. Tubiana-Hulin, BMC Cancer	2005	27
Single Circulating Tumor Cell Detection and Overall Survival in Non Metastatic Breast Cancer. F-C Bidard, Claire Mathiot, F. Mefti, Cancer Research Breast OncologyCancer ManagementPathologyOverall SurvivalTumor Biology	2009	20
A Three-Arm Randomized Phase II Study of Oral Vinorelbine Plus Capecitabine Versus Oral Vinorelbine and Capecitabine in Sequence Versus Docetaxel Plus Capecitabine in Patients with Metastatic Breast Cancer Previously Treated with Anthracyclines Mario Campone, Natalya Dobrovolskaya, Serjei Tjulandin, The Breast Journal	2013	19

Page 1